Atypical chemokine receptors in cancer: friends or foes? (Q38747771)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908826%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Atypical chemokine receptors in cancer: friends or foes? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908826%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908826%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908826%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Alberto Mantovani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908826%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Ornella Bonavita

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908826%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Massimo Locati

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908826%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

23 February 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908826%20AND%20SRC:MED&resulttype=core&format=json

Journal of Leukocyte Biology

8 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908826%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908826%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908826%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

927-933

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908826%20AND%20SRC:MED&resulttype=core&format=json

Chemokines and chemokine receptors: positioning cells for host defense and immunity

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Tuning inflammation and immunity by chemokine sequestration: decoys and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

New nomenclature for atypical chemokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Immune regulation by atypical chemokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

The chemokine system in cancer biology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Myeloid cells in cancer-related inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Targeting CCR4 as an emerging strategy for cancer therapy and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

CXC chemokines in cancer angiogenesis and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Homeostatic chemokine receptors and organ-specific metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Cancer and the chemokine network

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

CXCL12 (SDF-1)/CXCR4 pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Contribution of Duffy antigen to chemokine function

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Loss of red cell chemokine scavenging promotes transfusion-related lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

The global distribution of the Duffy blood group

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Distribution of Duffy Antigen Receptor for Chemokines (DARC) and Risk of Prostate Cancer in Barbados, West Indies

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

CD82/KAI expression prevents IL-8-mediated endothelial gap formation in late-stage melanomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

DARC (Duffy) and BCAM (Lutheran) reduced expression in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Regulation of the immune and inflammatory responses by the 'atypical' chemokine receptor D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Hemopoietic Cell Expression of the Chemokine Decoy Receptor D6 Is Dynamic and Regulated by GATA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Regulation of D6 chemokine scavenging activity by ligand- and Rab11-dependent surface up-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

β-arrestin-dependent activation of the cofilin pathway is required for the scavenging activity of the atypical chemokine receptor D6

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

The chemokine receptor D6 limits the inflammatory response in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

The atypical chemokine receptor D6 contributes to the development of experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Microarray analyses demonstrate the involvement of type I interferons in psoriasiform pathology development in D6-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Cell-autonomous regulation of neutrophil migration by the D6 chemokine decoy receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Expression of the chemokine decoy receptor D6 is decreased in colon adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

An analysis of the function and expression of D6 on lymphatic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

ERK-Dependent Downregulation of the Atypical Chemokine Receptor D6 Drives Tumor Aggressiveness in Kaposi Sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Potential combinatorial effects of recombinant atypical chemokine receptors in breast cancer cell invasion: A research perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Chemokine decoy receptor d6 plays a negative role in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Effect of genetic variants in two chemokine decoy receptor genes, DARC and CCBP2, on metastatic potential of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Atypical chemokine receptors predict lymph node metastasis and prognosis in patients with cervical squamous cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Prognostic impact of atypical chemokine receptor expression in patients with gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Atypical chemokine receptor D6 inhibits human non-small cell lung cancer growth by sequestration of chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Ubiquitination of CXCR7 controls receptor trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

The relevance of the chemokine receptor ACKR3/CXCR7 on CXCL12-mediated effects in cancers with a focus on virus-related cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Molecular Pathways: Targeting the CXCR4-CXCL12 Axis--Untapped Potential in the Tumor Microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

CXCR7, CXCR4 and CXCL12: an eccentric trio?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

ShRNA-mediated knock-down of CXCR7 increases TRAIL-sensitivity in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

The IL-8–Regulated Chemokine Receptor CXCR7 Stimulates EGFR Signaling to Promote Prostate Cancer Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Transmembrane receptor CXCR7 increases the risk of extrahepatic metastasis of relatively well-differentiated hepatocellular carcinoma through upregulation of osteopontin

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

The role of CXCR7 on the adhesion, proliferation and angiogenesis of endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

CXCR7: a novel tumor endothelial marker in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

The chemokine receptor CXCR7 influences prognosis in human glioma in an IDH1-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Cutting edge: identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Characterization of mouse CCX-CKR, a receptor for the lymphocyte-attracting chemokines TECK/mCCL25, SLC/mCCL21 and MIP-3beta/mCCL19: comparison to human CCX-CKR

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

β-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKR

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

CC chemokine receptor-like 1 functions as a tumour suppressor by impairing CCR7-related chemotaxis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

CCX-CKR expression in colorectal cancer and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

The atypical chemokine receptor CCX-CKR regulates metastasis of mammary carcinoma via an effect on EMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3MR0915-431RR

10.1189/JLB.3MR0915-431RR

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908826%20AND%20SRC:MED&resulttype=core&format=json

release_sy55ro5bbjhplkdezjlgyf75we

8 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sy55ro5bbjhplkdezjlgyf75we

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908826%20AND%20SRC:MED&resulttype=core&format=json